OnMedica People who take high potency statins – especially atorvastatin and simvastatin – are more likely to develop diabetes, according to a study published online today in the BMJ. However, experts have said that the benefits of taking statins still outweigh ...
PakTribune.com Their report said: "We found that patients treated with atorvastatin , rosuvastatin, or simvastatin were at increased risk of new onset diabetes compared with those treated with pravastatin. "Clinicians should considers this risk when they are ... and more »
CTV News The three drugs were atorvastatin, rosuvastatin and simvastatin , which are sold as Lipitor, Crestor and Zocor respectively. The researchers said no increased risk was seen with fluvastatin (which is sold under the brand names Lescol, Canef and Vastin ...
The Courier-Journal A small group of overweight or obese people were unable to make any significant fitness gains while taking a 40 milligram daily dose of simvastatin ...
WebMD.Boots.com For instance, patients treated with atorvastatin were found to have a 22% increased risk of new-onset diabetes, rosuvastatin an 18% increased risk and simvastatin a 10% increased risk, relative to pravastatin, which was used for comparison purposes.
Nature World News However, patients on other drugs such as fluvastatin were at a 5 percent decreased risk and those on lovastatin were at a 1 percent decreased risk of developing the condition. "Compared with pravastatin, treatment with higher potency statins ...
Toronto NewsFIX A group of 44 patients received either lovastatin , simvastatin or pravastatin, or niacin – a B vitamin. Statin treatment lowered levels of 24S-hydroxycholesterol by 21 per cent and total cholesterol by 25 per cent. Niacin could lower 24S ...
Daily Mail The study involved 1.5 million people in Ontario, Canada, and the statins involved were fluvastatin, lovastatin , pravastatin, simvastatin, atorvastatin and rosuvastatin. Researchers identified 471,250 patients with no history of diabetes and who were ...
